Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001473
What this trial is testing

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableEnded earlyNCT05781672
What this trial is testing

Prediction of Delayed Toxic Cardiomyopathy in Children

Who this might be right for
CardiotoxicityChildhood Cancer
University Hospital, Montpellier 134
Testing effectiveness (Phase 2)UnknownNCT03638375
What this trial is testing

TIL and Anti-PD1 in Metastatic Melanoma

Who this might be right for
Toxicity, DrugAdverse Drug EventEffects of Immunotherapy
Leiden University 34
Not applicableLooking for participantsNCT06664528
What this trial is testing

Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies

Who this might be right for
Cardiac ToxicityCancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Not applicableStudy completedNCT06586073
What this trial is testing

Topical Cosmetic Products for Hand and Foot Syndrome

Who this might be right for
Hand Foot Skin Syndrome
Dermophisiologique s.r.l 53
Not applicableStudy completedNCT03131024
What this trial is testing

Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects

Who this might be right for
Breast Cancer Female
University of Alberta 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Not applicableUnknownNCT01032278
What this trial is testing

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Who this might be right for
Cardiac ToxicityUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 597
Post-approval studies (Phase 4)Looking for participantsNCT06183437
What this trial is testing

The STOP-MED CTRCD Trial

Who this might be right for
Heart FailureCardiotoxicityCardiac Toxicity+2 more
Dinesh Thavendiranathan 335
Post-approval studies (Phase 4)Study completedNCT02739295
What this trial is testing

G-CSF in the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Stevens - Johnson Syndrome
University of Liege 10
Not applicableStudy completedNCT07073807
What this trial is testing

Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy

Who this might be right for
CancerNeoplasms
University of California, Irvine 35
Not applicableLooking for participantsNCT07491536
What this trial is testing

Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis

Who this might be right for
Oral MucositisChemotherapy-induced Oral MucositisHead and Neck Neoplasms
University of Pavia 50
Large-scale testing (Phase 3)Study completedNCT00358501
What this trial is testing

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Who this might be right for
Severe Hepatic Veno-Occlusive Disease
Jazz Pharmaceuticals 134
Large-scale testing (Phase 3)UnknownNCT04651439
What this trial is testing

Severe Bullous Drug Eruption and Filgrastim

Who this might be right for
Rare DiseasesToxic Epidermal Necrolyses
Hospices Civils de Lyon 42
Not applicableStudy completedNCT00000722
What this trial is testing

Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Not applicableNot Yet RecruitingNCT07408362
What this trial is testing

Early Diagnosis and Cardiovascular Risk Stratification in Children Exposed to Cancer Therapies

Who this might be right for
Cancer Therapy-related Cardiovascular ToxicityChildhood CancerChemotherapeutic Toxicity+2 more
Centre Hospitalier Universitaire de Liege 100
Large-scale testing (Phase 3)Ended earlyNCT05128773
What this trial is testing

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity

Who this might be right for
Breast Cancer
Sanofi 3
Testing effectiveness (Phase 2)UnknownNCT00003583
What this trial is testing

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
University of Florida 20
Not applicableLooking for participantsNCT07495072
What this trial is testing

Early vs Delayed Intravesical Blad-Care During BCG Therapy

Who this might be right for
Urinary Bladder NeoplasmsBCG-Induced Cystitis
BLAD-HYA Group 56
Not applicableUnknownNCT05063643
What this trial is testing

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude

Who this might be right for
HER2-positive Breast CancerTargeted TherapyCardiac Toxicity+1 more
Affiliated Hospital of Qinghai University 132
Next Page